News
Pulmonary Drug Delivery System Market Size to Worth USD 73.14 Billion by 2031 | The Insight Partners
According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...
Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.
A long-term real-world study of older adults with COPD shows that initiation of tiotropium is linked to a minimal increase in ...
Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.
Newly released Medicare national coverage determinations are set to reshape the home ventilation landscape for chronic ...
This study aimed to determine the prevalence of COPD and identify its associated risk factors in the population of Attecoube ...
However, they cautioned that there were no health-related quality of life, respiratory symptoms, or lung function benefits as previously seen with dupilumab (Dupixent) in a similar COPD population ...
In contrast, in the general US population, 85% of COPD deaths occur among adults aged 65 years or older, according to 2021 data from the US Centers for Disease Control and Prevention ...
When diagnosed with COPD, 86.2% of patients did not receive treatment, and after 4 years, 63.8% still had not been treated, according to results published in BMC Pulmonary Medicine.“There is an ...
BOSTON — Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk for fatal pulmonary embolism (PE) and may require personalized, targeted thromboprophylaxis. Those ...
COPD cases among younger individuals are on the rise due to factors such as smoking, vaping, air pollution, and exposure to biomass fuels. Urbanization and lifestyle changes, like poor nutrition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results